These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3882480)
1. Squaric acid dibutyl ester in the treatment of alopecia areata. Barth JH; Darley CR; Gibson JR Dermatologica; 1985; 170(1):40-2. PubMed ID: 3882480 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester. Giannetti A; Orecchia G Dermatologica; 1983; 167(5):280-2. PubMed ID: 6653853 [TBL] [Abstract][Full Text] [Related]
3. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation. Losol E; Şentürk N Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267 [TBL] [Abstract][Full Text] [Related]
4. Treatment of alopecia areata with squaric acid dibutylester. Micali G; Cicero RL; Nasca MR; Sapuppo A Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome. Ajith C; Gupta S; Kanwar AJ J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260 [TBL] [Abstract][Full Text] [Related]
6. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata. Guerra L; Pacifico V; Calabresi V; De Luca N; Castiglia D; Angelo C; Zambruno G; Di Zenzo G Br J Dermatol; 2017 Feb; 176(2):491-494. PubMed ID: 27208509 [TBL] [Abstract][Full Text] [Related]
7. [Squaric acid dibutyl ester in the treatment of severe alopecia areata]. Miranda A; Mato F; Quiñones PA Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620 [TBL] [Abstract][Full Text] [Related]
9. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study. Chua SH; Goh CL; Ang CB Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014 [TBL] [Abstract][Full Text] [Related]
10. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477 [TBL] [Abstract][Full Text] [Related]
11. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients. Orecchia G; Malagoli P; Santagostino L Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854 [TBL] [Abstract][Full Text] [Related]
12. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester]. Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332 [No Abstract] [Full Text] [Related]
13. Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE). Johansson E; Ranki A; Reunala T; Kianto U; Niemi KM Acta Derm Venereol; 1986; 66(6):485-90. PubMed ID: 2433867 [TBL] [Abstract][Full Text] [Related]
20. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians. Tan E; Tay YK; Goh CL; Chin Giam Y Int J Dermatol; 2002 Nov; 41(11):748-53. PubMed ID: 12452996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]